Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Summary of Changes in Level One and Level Three Financial Assets (Detail)

v3.24.3
Financial Instruments - Summary of Changes in Level One and Level Three Financial Assets (Detail) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Loss on equity method investments $ (162) $ (0)
4 Front Venture Corp [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 56  
Revaluations (28)  
Ending balance 28  
Other Long-term Investments [Member] | The Pharm Stand, LLC [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 0  
Additions 125  
Ending balance 125  
Other Long-term Investments [Member] | Island Thyme LLC [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 679  
Additions 195  
Loss on equity method investments (162)  
Ending balance $ 712